DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the NATURAL CAPSULES LIMITED (NATCAPSUQ) share price today?

NATURAL CAPSULES LIMITED (NATCAPSUQ) is trading at ₹142.55 on the NSE, up 0.31% on the day. Source: DocStoX.

What is the market capitalisation of NATURAL CAPSULES LIMITED?

NATURAL CAPSULES LIMITED has a market capitalisation of approximately ₹154 crore.

NATURAL CAPSULES LIMITED

NATCAPSUQ·NSE·Healthcare

₹142.55▲ +0.44 (+0.31%)

Healthcare · Pharmaceuticals

A steady, established business

Day₹141.85

₹143.40

52W₹136

₹2964%

Open

₹142.12

High

₹143.40

Low

₹141.85

Prev Close

₹142.11

Volume

1.0K

VWAP

₹142.09

Snapshot

Key fundamentals

Market Cap

₹154 Cr

P/E Ratio

N/A

P/B Ratio

0.68

EPS

₹-16.44

Book Value

₹226.00

ROE

-7.30%Weak

ROCE

-5.00%Weak

Dividend Yield

0.70%

Debt / Equity

0.49Moderate

Face Value

₹10.00

52W High

₹296.00

52W Low

₹136.36

Sector

Healthcare

Industry

Pharmaceuticals

Expensive

None moatHigh uncertainty

Fair value estimate

₹171

▲ 20.0%upside

Trading at ₹143 — 20% below our estimate

BearFair valueBull

₹145₹171₹197

/100

Business quality — Watch the fundamentals

Growth 13Profitability 0Efficiency 0Valuation 76

Plain English

Our view

A steady, established business
Low debt relative to equity
Weak returns on equity (-7%)

Strengths

Low debt relative to equity
Promoters hold a controlling stake

Risks

Weak returns on equity (-7%)
Fundamental red flags (Piotroski 3/9)

How we got there

Fair value methods

Residual income

-7% ROE fading to 13% over ~3 yrs, on ₹226 book

₹171

Relative P/E

Needs positive EPS

—

Graham floor

Needs positive EPS

—

Analyst target

No analyst coverage

—

Blended fair value₹171

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

Weak returns on equity (-7%)
Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

-7.3%Weak

Above 15% is considered healthy for Indian equities

ROCE

-5.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.49Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹154 Cr

P/B

0.68

EPS

₹-16.44

Div Yield

0.70%

What changed

Recent changes

Promoters-0.22% stake last quarter

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

Slow

+3% rev CAGR

Profitability

Loss-making

-7.3% ROE

Financial health

Comfortable

D/E 0.49

Momentum

N/A

No technicals

Today

Trading activity

Delivery %85.0%

Turnover₹1.45L Cr

Trades43

VWAP₹142.09

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+3.2%

+18.5%

10Y

+11.7%

Profit

—

10Y

—

EPS

—

10Y

—

Profile

Pros

Stock is trading at 0.64 times its book value

Watch-outs

Cons

Company has low interest coverage ratio.
Company has a low return on equity of -1.77% over last 3 years.
Contingent liabilities of Rs.70.8 Cr.
Promoter holding has decreased over last 3 years: -5.52%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters trimmed their stake by 0.22 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

51%

Promoter

Promoters

51.0%-0.22

Public

33.1%+0.11

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

15.9%

Total shareholders

8,850-225 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter51.04%

Public33.06%

Others15.90%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]